Live Activities
Treatment of Parkinson's Disease: Past, Present and Future

Course Faculty

Course Directors

Stanley Fahn, MD
Director, Movement Disorders Group
Neurological Institute
New York, NY, USA

Werner Poewe, MD
Director, Department of Neurology
Innsbruck Medical University
Innsbruck, Austria

Francisco Cardoso, MD, PhD
Professor of Neurology
The Federal University of Minas Gerais
Belo Horizonte, Brazil

Presenters

Angelo Antonini, MD, PhD • Venice, Italy
Francisco Cardoso, MD, PhD • Belo Horizonte, Brazil
Stanley Fahn, MD • New York, NY, USA
Susan Fox, MRCP(UK), PhD • Toronto, ON, Canada
Oscar Gershanik, MD • Buenos Aires, Argentina
Jennifer Goldman, MD, MS • Chicago, IL, USA
Horacio Kaufmann, MD • New York, NY, USA
Anthony Lang, OC, MD, FRCPC • Toronto, ON, Canada
Andrew Lees, MD, FRCP • London, United Kingdom
Peter LeWitt, MD • West Bloomfield, MI, USA
Elena Moro, MD, PhD • Grenoble, France
C. Warren Olanow, MD, FRCP • New York, NY, USA
Giselle Petzinger, MD • Los Angeles, CA, USA
Werner Poewe, MD • Innsbruck, Austria
Ron Postuma, MD, MSc • Montreal, QC, Canada
Matthew Stern, MD • Philadelphia, PA, USA
Eduardo Tolosa, MD • Barcelona, Spain


Course Program

March 21, 2014
Introduction
Chair: Matthew Stern, MD
8:00-8:30 L-dopa: History of Introduction into Clinical Practice
Stanley Fahn, MD 
8:30-8:50 Overview of EBM management of PD
Jennifer Goldman, MD, MS
8:50-9:20 Details of clinical trials and evidence of efficacy of L-dopa
Eduardo Tolosa, MD 
9:20-9:40 Is there a place for non-dopaminergic agents?
Francisco Cardoso, MD, PhD
9:40-10:00 Place of exercise in the management of PD
Giselle Petzinger, MD
10:00-10:30 Coffee Break
Mild Stage
Chair: Oscar Gershanik, MD
10:30-10:50 L-dopa monotherapy: pros and cons
Andrew Lees, MD, FRCP
10:50-11:10 Dopamine agonist monotherapy: pros and cons
Anthony Lang, OC, MD, FRCPC
11:10-11:30 MAO inhibitors: pros and cons
Matthew Stern, MD, FRCPC
11:30-12:00 Panel Discussion
12:00-1:00 Lunch
Discussion of Early Stage Cases
1:00-2:00 Small group breakouts to view case presentations 
Oscar Gershanik, MD
Anthony Lang, OC, MD, FRCPC
Andrew Lees, MD, FRCP
C. Warren Olanow, MD, FRCPC
Giselle Petzinger, MD
Matthew Stern, MD
Advanced Stage - Non-Motor Features
Chair: Stanley Fahn, MD
2:10-2:40 Cognition and psychosis
Jennifer Goldman, MD, MS
2:40-3:10 Depression, apathy and anxiety
Angelo Antonini, MD, PhD 
3:10-3:30 Break
3:30-4:00 Sleep disorder
Giselle Petzinger, MD 
4:00-4:30 Dysautonomia
Horacio Kaufmann, MD
4:30-5:00 Medication-induced behavioral problems
Anthony Lang, MD 
Discussion of Advanced Stage Cases - Non-Motor Features
5:10-6:10








End of sessions
(approx. 6:15-8:00)
Small group breakouts to view case presentations 
Angelo Antonini, MD, PhD
Francisco Cardoso, MD, PhD
Susan Fox, MRCP(UK), PhD
Jennifer Goldman, MD, MS
Peter LeWitt, MD
Eduardo Tolosa, MD
 

Welcome reception for all attendees


 
March 22, 2014
Advanced Stage - Motor Features
Chair: Francisco Cardoso, MD, PhD
8:30-9:00 Fluctuations and dyskinesias - mechanisms and clinical features
Susan Fox, MRCP(UK), PhD
9:00-9:30 Fluctuations and dyskinesias - pharmacological treatment
Peter LeWitt, MD
9:30-10:00 Fluctuations and dyskinisias - surgical treatment
Elena Moro, MD, PhD
10:00-10:30 Postural abnormalities, falls and freezing
Eduardo Tolosa, MD
10:30-11:00 Break
Discussion of Advanced Stage Cases - Motor Features
11:00-12:00 Small group breakouts to view case presentations
Francisco Cardoso, MD, PhD
Stanley Fahn, MD
Peter LeWitt, MD
Elena Moro, MD, PhD
Werner Poewe, MD
Eduardo Tolosa, MD 
12:00-1:00 Lunch
Moving Forward
Chair: C. Warren Olanow, MD, FRCPC
1:00-1:30 Disease modifying strategies: an elusive goal
C. Warren Olanow, MD, FRCPC 
1:30-2:00 Novel deliveries of dopaminergic agents
Werner Poewe, MD 
2:00-2:30 Future of surgical treatment in PD - I: DBS
Elena Moro, MD, PhD
2:30-3:00 Future of surgical treatment in PD - II: gene and cell-based therapies
C. Warren Olanow, MD, FRCPC 
3:00-3:30 The pharmacological pipeline: what a clinician can expect
Werner Poewe, MD